Material and Method: A retrospective study was conducted wherein all the bone marrow aspirate smears diagnosed as HLH between January 2015 to June 2018 were reviewed. Detailed correlation of clinical and laboratory criteria was done with the bone marrow findings. Results: A total of twelve cases were diagnosed as HLH from January 2015 to June 2018. Ten patients fulfilled 5 out of 8 clinical and lab diagnostic criteria of HLH (2004). After correlating clinical and laboratory criteria along with bone marrow findings the diagnosis of HLH was suggested.
Conclusion: We present a series of twelve cases of Hemophagocytic Lymphohistiocytosis from a tertiary care hospital in New Delhi which will add not only to the understanding of this rare life threatening disease but also to the early diagnosis and intervention.
Diagnostic criteria for HLH were proposed in 1991 and updated in 2004 [7,8]. The 2004 criteria are as follows. The diagnosis requires the presence of either criterion A or 5 out of 8 of criterion B.
Diagnostic criteria for HLH (2004)
A. Familial disease/known genetic defect
OR
B. Clinical/laboratory criteria
1. Fever,
2. Splenomegaly,
3. Cytopenia (at least 2 cell lines)
HGB < 9 gram/dL,
PLT< 100,000/microL,
ANC< 1000/microL
4. Hypertryglyceridemia and/or hypofibrinogenemia,
Fasting triglyceride> 265 mg/dL, Fibrinogen < 150 mg/L,
5. Hyperferritinemia, Ferritin>500ug/l
6. Hemophagocytosis in bone marrow, CSF, or lymph
nodes,
7. Decreased/absent NK cell activity
8. Soluble CD25 > 2400 U/ml.
The requisition forms of the same were reviewed to get all relevant clinical and laboratory details. Bone marrow smear findings were correlated with clinical and laboratory findings.
Table I: Laboratory features of patients.
We could determine the underlying etiology in 11/12 patients. An infectious cause was found in 6/12 patients (50%) [1-CMV, 1 -Dengue, 1- hepatitis B, 1- Typhoid, 1-TB, 1- Rickettsia]. Ramachandran et al. similarly found an infectious cause in 42% of the pediatric patients and Joshi et al. in 30% of the patients [11,12]. Out of the infectious causes, the most commonly responsible ones are viral{EBV, CMV, parvovirus] followed by bacterial [Brucella, TB], parasitic [Leishmaniasis] and fungal infections [15,16]. One of the patient in the present series was a suspected case of uncomplicated dengue fever who presented with fever and macular rash on the abdomen [third day of fever] along with anemia and thrombocytopenia. Dengue virus is a very uncommon cause of HLH with most of the reported cases being associated with complicated hemorrhagic cases [17-19]. However, our case was of uncomplicated dengue as has been previously reported once [20]. This patient had very high levels of ferritin, LDH, triglycerides and was thus diagnosed to have HLH, even though the bone marrow failed to reveal hemophagocytosis. Hemophagocytosis may not be evident in very early stages of HLH, and thus its absence does not negate the diagnosis of HLH [21]. The incidence of bone marrow involvement varies between 25% and 100% [22]. This implies that the diagnosis of HLH requires a comprehensive clinical, biochemical and hematological approach.
HLH is a diagnostic challenge to clinicians as its presenting signs and symptoms are non specific and thus portend a wide array of differential diagnoses. The presenting signs involve multiple organs and hence multiorgan disorders like sepsis, MODS, etc. come into close differentials. It has been found that cytopenias and extremely high ferritin levels are most helpful in diagnosing HLH [3]. The closest differential in pediatric patients is sepsis. Palazzi et al. in their series of pediatric PUO patients found that very high levels of ferritin and LDH were highly suggestive of HLH [23]. Other differentials include multiple organ dysfunction syndrome [MODS], liver failure, and encephalitis. Again increasing levels of ferritin, high LDH and cytopenias accompanied by evidence of bone marrow hemophagocytosis help in clinching the diagnosis [3]. For familial HLH the only confirmatory test is genetic testing for mutations, the most common being mutations in the perforin gene [3]. However, this is available in only limited laboratories. Recently, flow cytometry for perforin expression has been introduced for screening of HLH. It can prove to be useful as it is economical and readily available [24].
is difficult to establish a preset diagnostic approach for reaching the right diagnosis. Most of the patients are seriously ill and present with signs and symptoms pertaining to multiple organs, i.e. central nervous system abnormalities, liver function dysfunction, bone marrow insufficiency, immune dysfunction, etc. Sometimes all the criteria for HLH are not met but a high index of suspicion is required for the diagnosis of such cases in the initial stages. All patients with prolonged fever and cytopenias must be evaluated for HLH by obtaining a detailed history, performing a detailed physical examination and by using the relevant biochemical tests. The history should aim at finding out the underlying etiology, so the patient should be asked about pre-existing viral illness, fever to rule out infectious causes, history of fever with joint pains to rule out underlying autoimmune joint disease and history of significant weight loss and any other symptoms for underlying malignancy. The physical examination should include detailed search for lymphadenopathy, hepatosplenomegaly, and complete examination of all the organ systems. In addition laboratory tests should be ordered to confirm the suspected etiology like complete blood count and blood, urine, CSF culture to establish infective cause, and CT neck, abdomen, etc. to rule out malignant etiology, etc. Additional tests like ferritin, triglycerides, LDH and fibrinogen will confirm the diagnosis. Bone marrow examination should be done and diligently searched for hemophagocytosis. Cr release assays to measure NK cell activity and measurement of sCD25 are also helpful to arrive at the diagnosis; however, these tests are not readily available and hence cannot be relied upon. It is imperative to differentiate genetic HLH from secondary HLH as the latter is treatable by finding the underlying cause. Management of secondary HLH cases includes antiviral agents for virus associated cases, antibiotics, antiparasitic drugs, and antifungal agents for bacterial, parasitic and fungus associated cases respectively. For genetic HLH, stem cell transplantation is the only effective therapy.
The 2004 HLH treatment protocol by the Histiocyte Society recommends use of 8 weeks of induction therapy of cyclosporine, etoposide and corticosteroids (25). Permanent cure is possible only with stem cell transplantation but treatment of the underlying cause is indicated for acquired HLH. In the present series, all the patients diagnosed as HLH were treated with corticosteroids. In addition, antiviral agents were given in the cases found to be positive for CMV and Parvovirus, and ceftriaxone was given to the case found to be typhidot positive. All the patients were followed for a period of two months following which all showed improvement and were ultimately discharged.
The prognosis of genetic HLH is dismal [25]. The prognosis of acquired HLH is variable depending on the underlying cause, with malignancy associated cases having the worst outcome [26].
In conclusion, HLH is an uncommon, fatal but underdiagnosed disease. The symptoms of the disease are non specific, mimicking many conditions and hence requires a high index of suspicion for making a timely diagnosis. In view of the paucity of data from the Indian subcontinent, this study is an attempt for better understanding and early diagnosis of the disease as it will pave the way for better management of the patients.
CONFLICT of INTEREST
The authors declare no conflict of interest.
FUNDING
None
1) Farquhar JW, Claireaux AE. Familial haemophagocyticreticulosis.
Arch Dis Child. 1952;27:519-25.
2) Janka GE. Familial and acquired hemophagocytic
lymphohistiocytosis. Annu Rev Med. 2012;63:233-46.
3) McClain K. Clinical features and diagnosis of hemophagocytic
lymphohistiocytosis. Up To Date - Topic 87499 Version 1.0
4) Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis:
An update on diagnosis and pathogenesis. Am J Clin Pathol.
2013;139:713-27.
5) Parodi A, Davì S, Pringe AB, Pistorio A, Ruperto N, Magni-
Manzoni S, Miettunen P, Bader-Meunier B, Espada G, Sterba G,
Ozen S, Wright D, Magalhães CS, Khubchandani R, Michels H,
Woo P, Iglesias A, Guseinova D, Bracaglia C, Hayward K, Wouters
C, Grom A, Vivarelli M, Fischer A, Breda L, Martini A, Ravelli A;
Lupus Working Group of the Paediatric Rheumatology European
Society. Macrophage activation syndrome in juvenile systemic
lupus erythematosus: A multinational multicenter study of
thirty-eight patients. Arthritis Rheum. 2009;60:3388-99.
6) Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage
activation syndrome in autoimmune disease. Int Arch Allergy
Immunol. 2010;153:109-20.
7) Henter JI, Elinder G, Söder O, Ost A. Incidence in Sweden and
clinical features of familial hemophagocytic lymphohistiocytosis.
Acta Paediatr Scand. 1991;80:428-35.
8) Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku
S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-
2004: Diagnostic and therapeutic guidelines for hemophagocytic
lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-31.
9) Reddy S, Rangappa P, Kasaragod A, Kumar AS, Rao K.
Haemophagocytic lymphohistiocytosis (HLH): Case series in
tertiary referral hospital over three years. J Assoc Physicians
India. 2013;61:850-2.
10) Rajagopala S, Singh N, Agarwal R, Gupta D, Das R. Severe
hemophagocytic lymphohistiocytosis in adults-experience from
an intensive care unit from North India. Indian J Crit Care Med.
2012;16:198-203.
11) Joshi R, Phatarpekar A, Currimbhoy Z, Desai M.
Haemophagocytic lymphohistiocytosis: A case series from
Mumbai. Ann Trop Paediatr. 2011;31:135-40.
12) Ramachandran B, Balasubramanian S, Abhishek N, Ravikumar
KG, Ramanan AV. Profile of hemophagocytic lymphohistiocytosis
in children in a tertiary care hospital in India. Indian Pediatr.
2011;48:31-5.
13) Gopal GK, Anugrah C, Boorugu H. Scrub typhus associated
macrophage activation syndrome. Trop Doct. 2010;40:249-50.
14) Rajagopala S, Dutta U, Chandra KS, Bhatia P, Varma N,
Kochhar R. Visceral leishmaniasis associated hemophagocytic
lymphohistiocytosis-case report and systematic review. J Infect.
2008;56:381-8.
15) Risdall RJ, Brunning RD, Hernandez JI, Gordon DH. Bacteria
associated hemophagocytic syndrome. Cancer. 1984;54:2968-72.
16) Sung PS, Kim IH, Lee JH, Park JW. Hemophagocytic
Lymphohistiocytosis (HLH) Associated with Plasmodium vivax
Infection: Case report and review of the literature. Chonnam
Med J. 2011;47:173-6.
17) Ramanathan M, Duraisamy G. Haemophagocytosis in dengue
haemorrhagic fever: A case report. Ann Acad Med Singapore.
1991;20:803-4.
18) Rueda E, Mendez A, Gonzalez G. Hemophagocytic syndrome
associated with dengue hemorrhagic fever. Biomedica.
2002;22:160-6.
19) Lu PL, Hsiao HH, Tsai JJ, Chen TC, Feng MC, Chen TP,
Lin SF. Dengue virus associated hemophagocytic syndrome
and dyserythropoiesis: A case report. Kaohsiung J Med Sci.
2005;21:34-9.
20) Jain D, Singh T. Dengue virus related hemophagocytosis: A rare
case report. Hematology. 2008;13:286-8.
21) Gupta A, Tyrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem
M. The role of the initial bone marrow aspirate in the diagnosis
of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer.
2008:51:402-4.
22) Siddaiahgari SR, Agarwal S, Madukuri P, Moodahadu LS.
Hemophagocytic Lymphohistiocytosis: A Review. J Blood Disord
Transfus. 2016;7:363.
23) Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome
in children: An important diagnostic consideration in fever of
unknown origin. Clin Infect Dis. 2003;36:306-12.
24) Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich
AH. Perforin expression in cytotoxic lymphocytes from patients
with hemophagocytic lymphohistiocytosis and their family
members. Blood. 2002;99:61-6.